Bone morphogenetic protein receptor type Ia localization causes increased BMP2 signaling in mice exhibiting increased peak bone mass phenotype

Journal of Cellular Physiology

Volumn 227, Issue 7, 2012, Pages 2870-2879

  Bragdon, Beth ^a,b   Bonor, Jeremy ^a   Shultz, Kathryn L ^c   Beamer, Wesley G ^c   Rosen, Clifford J ^d   Nohe, Anja ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c JACKSON LABORATORY   (United States)

^d Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CAVEOLIN 1; SMAD PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MASS; CAVEOLA; CELL MEMBRANE; CELL SURFACE; CHROMOSOME 1; CONTROLLED STUDY; DIFFERENTIATION; FEMALE; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; REPORTER GENE; SIGNAL TRANSDUCTION; SPECTROSCOPY; STROMA CELL;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE MARROW; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CALCIFICATION, PHYSIOLOGIC; CAVEOLAE; CAVEOLIN 1; CELL MEMBRANE; FEMALE; MICE; MICE, CONGENIC; MICE, INBRED C3H; MICE, INBRED C57BL; OSTEOGENESIS; PHENOTYPE; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; SMAD PROTEINS; STROMAL CELLS;

MUS;

EID: 84858680174     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23028     Document Type: Article

References (43)

1. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. 1996. Genetic variability in adult bone density among inbred strains of mice. Bone 18: 397-403.
2. Beamer WG, Shultz KL, Ackert-Bicknell CL, Horton LG, Delahunty KM, Coombs HF III, Donahue LR, Canalis E, Rosen CJ. 2007. Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes. J Bone Miner Res 22: 1187-1196.
3. Bonor J, Adams EL, Bragdon B, Moseychuk O, Czymmek KJ, Nohe A. 2011. Initiation of BMP2 signaling in domains on the plasma membrane. J Cell Physiol. In press.
4. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. 2011. Bone morphogenetic proteins: A critical review. Cell Signal 23: 609-620.
5. Bragdon B, Thinakaran S, Bonor J, Underhill TM, Petersen NO, Nohe A. 2009. FRET reveals novel protein-receptor interaction of bone morphogenetic proteins receptors and adaptor protein 2 at the cell surface. Biophys J 97: 1428-1435.
6. Bragdon B, Thinakaran S, Moseychuk O, King D, Young K, Litchfield DW, Petersen NO, Nohe A. 2010. Casein kinase 2 beta-subunit is a regulator of bone morphogenetic protein 2 signaling. Biophys J 99: 897-904.
7. Brown CM, Petersen NO. 1998. An image correlation analysis of the distribution of clathrin associated adaptor protein (AP-2) at the plasma membrane. J Cell Sci 111: 271-281.
8. Chang H, Brown CW, Matzuk MM. 2002. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 23: 787-823.
9. Chiellini C, Cochet O, Negroni L, Samson M, Poggi M, Ailhaud G, Alessi MC, Dani C, Amri EZ. 2008. Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation. BMC Mol Biol 9: 26.
10. Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH. 2011. Bone remodelling at a glance. J Cell Sci 124: 991-998.
11. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. 2003. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5: 410-421.
12. Fujimoto T, Kogo H, Nomura R, Une T. 2000. Isoforms of caveolin-1 and caveolar structure. J Cell Sci 113 Pt 19: 3509-3517.
13. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, Henis YI, Knaus P. 2006. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 26: 7791-7805.
14. Hata K, Nishimura R, Ikeda F, Yamashita K, Matsubara T, Nokubi T, Yoneda T. 2003. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14: 545-555.
15. Judex S, Donahue LR, Rubin C. 2002. Genetic predisposition to low bone mass is paralleled by an enhanced sensitivity to signals anabolic to the skeleton. Faseb J 16: 1280-1282.
16. Kamiya N, Ye L, Kobayashi T, Lucas DJ, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ, Mishina Y. 2008. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res 23: 2007-2017.
17. Kaps C, Hoffmann A, Zilberman Y, Pelled G, Haupl T, Sittinger M, Burmester G, Gazit D, Gross G. 2004. Distinct roles of BMP receptors Type IA and IB in osteo-/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2). Biofactors 20: 71-84.
18. Lajoie P, Goetz JG, Dennis JW, Nabi IR. 2009. Lattices, rafts, and scaffolds: Domain regulation of receptor signaling at the plasma membrane. J Cell Biol 185: 381-385.
19. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC. 2000. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792.
20. Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, Hanks MC, Amling M, Pinero GJ, Harada S, Behringer RR. 2004. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 279: 27560-27566.
21. Mishra L, Marshall B. 2006. Adaptor proteins and ubiquinators in TGF-beta signaling. Cytokine Growth Factor Rev 17: 75-87.
22. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. 2004. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3: 379-389.
23. Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K. 2003. Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation. J Bone Miner Res 18: 1854-1862.
24. Nohe A, Keating E, Fivaz M, van der Goot FG, Petersen NO. 2006. Dynamics of GPI-anchored proteins on the surface of living cells. Nanomedicine 2: 1-7.
25. Nohe A, Keating E, Knaus P, Petersen NO. 2004a. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16: 291-299.
26. Nohe A, Keating E, Loh C, Underhill MT, Petersen NO. 2004b. Caveolin-1 isoform reorganization studied by image correlation spectroscopy. Faraday Discuss 126: 185-195 (discussion 245-254).
27. Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO. 2003. Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways. J Cell Sci 116: 3277-3284.
28. Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO. 2005. Dynamics and interaction of caveolin-1 isoforms with BMP-receptors. J Cell Sci 118: 643-650.
29. Nohe A, Petersen NO. 2004a. Analyzing for co-localization of proteins at a cell membrane. Curr Pharm Biotechnol 5: 213-220.
30. Nohe A, Petersen NO. 2004b. Analyzing protein-protein interactions in cell membranes. Bioessays 26: 196-203.
31. Nohe A, Petersen NO. 2007. Image correlation spectroscopy. Sci STKE 417: p. l7.
32. Ovchinnikov DA, Selever J, Wang Y, Chen YT, Mishina Y, Martin JF, Behringer RR. 2006. BMP receptor type IA in limb bud mesenchyme regulates distal outgrowth and patterning. Dev Biol 295: 103-115.
33. Ponce ML, Koelling S, Kluever A, Heinemann DE, Miosge N, Wulf G, Frosch KH, Schutze N, Hufner M, Siggelkow H. 2008. Coexpression of osteogenic and adipogenic differentiation markers in selected subpopulations of primary human mesenchymal progenitor cells. J Cell Biochem 104: 1342-1355.
34. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP. 2001. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 276: 6727-6738.
35. Semrau S, Schmidt T. 2009. Membrane heterogeneity-From lipid domains to curvature effects. Soft Matter 5: 3174-3186.
36. Sieczkarski SB, Whittaker GR. 2002. Dissecting virus entry via endocytosis. J Gen Virol 83: 1535-1545.
37. Skillington J, Choy L, Derynck R. 2002. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 159: 135-146.
38. Sottile V, Seuwen K. 2000. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 475: 201-204.
39. Thomas CM, Smart EJ. 2008. Caveolae structure and function. J Cell Mol Med 12: 796-809.
40. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V. 2006. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38: 1424-1429.
41. Wang A, Ding X, Sheng S, Yao Z. 2010. Bone morphogenetic protein receptor in the osteogenic differentiation of rat bone marrow stromal cells. Yonsei Med J 51: 740-745.
42. Yeh LC, Unda R, Lee JC. 2000. Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol 185: 87-97.
43. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, Hanai J, Nogami H, Ochi T, Miyazono K, Ito Y. 2000. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97: 10549-10554.